Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
MINNEAPOLIS, Sept. 12, 2016 -- Vital Images, Inc. (Vital), a Minneapolis-based advanced medical imaging and informatics company, is pleased to announce the support of Nuance PowerScribe® 360 Reporting and PenRad™ PenLung™ Lung Screening Management system in its comprehensive Lung Screening solution. The Vitrea® CT Lung Analysis application helps clinicians standardize the diagnosis of lung nodules, while the solution’s workflow system facilitates management of lung screening treatment plans.
Nuance’s PowerScribe 360 is the market-leading speech recognition technology for radiology, providing accurate, flexible and rapid reporting that is consistent and actionable. The high-quality reports generated by PowerScribe 360 can help healthcare organizations improve both patient care and physician satisfaction, and optimize billing and reimbursement.
PenLung by PenRad is a unified software solution that helps radiology departments and imaging facilities manage patients participating in low-dose computed tomography (LDCT) lung screening programs. It collects smoking and environmental risk history through automated web and tablet calculators to manage patient eligibility and export of the lung registry for reimbursement.
“We are excited to announce the support of PowerScribe 360 and PenLung as part of our comprehensive Lung Screening solution offering to healthcare organizations,” says Jim Litterer, President and CEO of Vital. “The integration of these powerful tools with CT Lung Screening can help providers continue to improve patient outcomes by streamlining both workflow and treatment plan management.”
About Vital Images, Inc.
Vital Images, Inc., a Toshiba Medical Systems Group company, is a leading provider of diagnostic imaging and enterprise informatics solutions to help healthcare organizations deliver exceptional care while optimizing resources across multi-facility organizations. The company's solutions are scalable to meet the unique needs of hospitals and imaging centers and are accessible throughout the enterprise anytime, anywhere. For more information, visit www.vitalimages.com or join the conversation on Twitter, LinkedIn and YouTube.
Vitrea is a trademark of Vital Images, Inc.
Marks not owned by Vital Images, Inc. are the property of their respective holders.
AT VITAL IMAGES: Aaron Wangen (952) 487-9632 [email protected] www.vitalimages.com
